PHARMACOLOGY

1. HEPARIN
2. CCB
3. METHOTREXATE
4. FAMOTIDINE
5. KETOROLAC
6. CHLOROQUINE
7. BENZODIAZIPINE
8. FRUSEMIDE
9. RADIO ACTIVE IODINES
10. ORAL ANTIDIABETIC AGENTS
11. LOOP DIURETICS
12. VASODIALATORS IN CONGESTIVE CARDIAC FAILURE
13. TREATMENT PLAN IN DRUG RESISTANT TB
14. SELECTIVE BETA BLOCKERS
15. TREATMENT OF ACC. HTN
16. DRUG THERAPY IN PUL. HTN
17. RECENT H2 RECEPTOR ANTAGONISTS
18. TREATMENT OF METHYL ALCOHOL POISONING
19. CHOICE OF ANAESTHETIC AGENTS IN CORONARY PATIENTS
20. BETA LACTAMASE INHIBITORS
21. DIGOXIN
22. PHENOBARBITONE
23. CHEMOTHERAPY OF MULTIPLE MYELOMA
24. DMARDS
25. STENTS
26. USES OF BROMOCRIPTINE
27. ASPIRIN RESISTANCE
28. TOXICITY OF DIGOXIN
29. CURRENT STATUS OF -BLOCKERS IN CCP
30. ROLE OF GABA ANALOGUES IN EPILEPSY
31. INDAPANIDE
32. RECENT DRUGS IN PARKINSONS
33. NEWER INSULINGS
34. ANTI AMOEBIC DRUGS
35. DRUG ADDICTIONS
36. ANTIMITOTICS
37. PC SK9 INHIBITORS
38. NEWER SGLT2 INHIBITORS
39. COMBINATIONS ANTI RETRO VIRAL THERAPY
40. TRICYCLIC ANTIDEPRESSANTS
41. ADVERSE EFFECTS AND USES OF ASPIRIN
42. TREATMENT OF CHLOROQUINE RESISTANT MALARIA
43. CLASSIFY THE ANTI-HYPERTENSIVE DRUGS. ADD A NOTE ON ONE LATEST
ANTI HYPERTENSIVE DRUG
44. DOTS THERAPY
45. NITRIC OXIDE
46. DRUG INTERACTIONS
47. SULFASALAZINE
48. VITAMIN EXCESS
49. NEWER QUINOLONES
50. ANTI-MALARIAL DRUGS
51. ANTI-VIRAL DRUGS
52. OHA
53. ANTIRETROVIRAL DRUGS
54. ANTIHELMINTHICS
55. ANTI ARRHYTHMIC DRUGS
56. COAGULANTS AND ANTI COAGULATNS
57. ANTI EPILEPTIC
58. ANTI THYROID
59. STATINS
60. SIDE EFFECTS OF -BLOCKERS
61. ADVERSE EFFECTS OF PHENYTOIN
62. VANCOMYCIN
63. QUININE
64. NEWER ANTI PLATELET DRUGS
65. NEWER MACROLIDES
66. ADVERSE EFFECTS OF CARBAMAZEPINE
67. INSULIN ANALOGUE-CLINICALS USE AND BENEFITS OVER HUMAN INSULIN
68. CLINICAL ADVANTAGES OF CARBIDOPA
69. ANGIOTENSIN RECEPTOR BLOCKERS-CLINICAL USE
70. ROSUVASTATINS- INDICATIONS, MOA, BENEFITS
71. AZITHROMYCIN-INDICATIONS, ADVERSE REACTIONS
72. DPP IV INHIBITORS-INDICATIONS AND CLINICAL BENEFITS
73. DISCUSS BOSETAN
74. CLINICAL USE OF CARBAPENAMS
75. DAPTOMYCIN-INDICATIONS AND ADVERSE REACTIONS
76. FIBRATES- INDICATIONS AND SIDE EFFECTS
77. SODIUM NITROPRUSSIDE
78. TOLVAPTAN
79. INSULIN DEGLUDEC
80. NEWER ANTIMALARIAL
81. H1 BLOCKERS
82. STEM CELL THERAPY
83. CLASSIFY DIURETICS, ADD NOTES ON METOLAZONE
84. BIOLOGIC THERAPY IN TREATMENT OF MALIGNANCY
85. TENOFOVIR
86. BIOLOGICALS IN TREATMENT OF RHEUMATOID ARTHRITIS
87. AMIDARONE
88. RECOMBINANT TISSUE PLASMINOGEN ACTIVATORS
89. DRUG THERAPY FOR XDR-TB
90. COMMON COMPLICATIONS OF ANTIBIOTICS
91. BIOSIMILARS- THE FUTURE OF BIOLOGICALS DRUGS
92. ECHINOCARDINS
93. DRUG ACTIONS ON AUTONOMIC NERVOUS SYSTEM
94. ALCOHOL
95. VACCINES AND IMMUNE SERA